跳至主要内容
临床试验/CTRI/2024/01/062079
CTRI/2024/01/062079尚未招募1 期

A study to investigate the antiretroviral drug in Ayurveda.

Satyananda yoga and Ayurveda Research institute Motihari1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年10月4日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
500
试验地点
1
主要终点
Increasing Ojas immune function to decrease viral load.

研究概览

简要总结

AIDS is a fetal illness coused by Humam immunodeficiency Virus HIV which breaks down the host immune system. This is responsible for the progressive immune system damage in Infected  person. In Ayurveda AMRITA  Tablet is an ideal herbal formulations of the mainly Rasayana drugs.Rasayana drug enhancing immunity for optimal level of Rasrakadi dhatu.It promotes strenght Vitality longevity and  improve mental faculties. In this  perspective there are two main two objectives can be study the immunological and virudical effect of Amrita Tablet on HIV positive patients. First assess the Amrita Tablet for restoration of Immunological function and suppression of viral load and second to evaluate the effect of AMRITA Tablet on the psychometric properties of WHOQOL HIV -Bref in infected adults.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Double

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosis to be HIV Positive.

排除标准

  • Taking immunomodulatory drugs Patient of antiretroviral Therapy Pregnancy or lactation Children.

结局指标

主要结局

Increasing Ojas immune function to decrease viral load.

时间窗: 24 weeks

次要结局

  • Measuring the psychometric properties of WHOQOL HIV Bref to improve the quality of life

研究者

发起方
Satyananda yoga and Ayurveda Research institute Motihari
申办方类型
Research institution
责任方
Principal Investigator
主要研究者

DrBrajeshwar Mishra

YCB Ministry of AYUSH

研究点 (1)

Loading locations...

相似试验